Chopas James George

Insider CIK 1836430 · RDUS Principal Finance Accounting · APLS VP/Chief Accounting Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	21,750	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	11,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	20,853	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	12,086	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	15,114	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	8,075	—	$0	8,075	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	16,150	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	16,150	—	$0	16,150	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	8,394	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	8,394	—	$0	8,394	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	6,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	16,150	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	9,444	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	4,156	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	8,075	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-05-14	2026-05-14	5,625	—	$0	5,625	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	5,625	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	2,406	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	65,955	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-01-28	2026-01-30	16,150	—	$0	65,955	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-22	2026-01-23	2,064	$21.77	$44.9K	49,805	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-20	2026-01-21	726	$19.79	$14.4K	51,869	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2026-01-13	2026-01-15	873	$22.19	$19.4K	52,595	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-09-15	2025-09-17	189	$24.19	$4.6K	53,468	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-09-02	2025-09-03	548	$28.08	$15.4K	53,657	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2025-06-18	2025-06-20	6,250	—	$0	54,205	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2025-06-09	2025-06-11	11,250	$19.39	$218.1K	11,250	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-03-17	2025-03-18	183	$24.82	$4.5K	47,955	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-22	2025-01-23	1,096	$30.43	$33.4K	48,138	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2025-01-21	2025-01-21	12,591	—	$0	49,234	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-17	2025-01-21	715	$29.96	$21.4K	36,643	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2025-01-13	2025-01-14	783	$28.70	$22.5K	37,358	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-09-16	2024-09-17	192	$36.21	$7.0K	38,141	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-09-03	2024-09-04	550	$39.49	$21.7K	38,333	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-03-15	2024-03-18	184	$56.46	$10.4K	38,883	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-22	2024-01-23	1,061	$65.00	$69.0K	39,067	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2024-01-16	2024-01-17	12,086	$66.30	$801.3K	12,086	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2024-01-16	2024-01-17	864	$66.81	$57.7K	40,128	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2024-01-16	2024-01-17	8,312	—	$0	40,992	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-10-23	2023-10-24	132	$46.04	$6.1K	32,680	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-09-14	2023-09-18	2,500	—	$0	32,812	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-08-31	2023-09-01	551	$41.23	$22.7K	30,312	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-02-21	2023-02-22	5,737	—	$0	5,737	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-02-21	2023-02-22	334	$58.50	$19.5K	30,863	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-02-21	2023-02-22	4,044	—	$0	31,197	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2023-01-20	2023-01-24	919	$52.05	$47.8K	27,153	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-01-12	2023-01-17	15,114	$52.66	$795.9K	15,114	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-01-12	2023-01-17	9,621	—	$0	28,072	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-10-20	2022-10-24	130	$58.00	$7.5K	18,451	SEC↗
APLS Apellis Pharmaceuticals, I	F Tax w/h	2022-08-30	2022-08-31	558	$58.84	$32.8K	18,581	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2022-01-21	2022-01-25	9,892	—	$0	9,892	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2022-01-21	2022-02-07	15,116	—	$0	15,116	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2022-01-21	2022-01-25	6,974	—	$0	15,456	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2022-01-21	2022-02-07	10,657	—	$0	19,139	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-10-20	2021-10-27	882	—	$0	8,482	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-08-30	2021-09-01	21,750	—	$0	21,750	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2021-08-30	2021-09-01	7,600	—	$0	7,600	SEC↗
RDUS Radius Health, Inc.	S Sale	2021-03-05	2021-03-09	370	$20.88	$7.7K	6,701	SEC↗
RDUS Radius Health, Inc.	A Award deriv	2021-02-22	2021-02-23	20,000	—	$0	20,000	SEC↗
RDUS Radius Health, Inc.	A Award deriv	2021-01-20	2021-01-21	20,000	—	$0	20,000	SEC↗